Endocyte, Inc. (ECYT) Reports Q2 Loss of $0.15
Tweet Send to a FriendGet Alerts ECYT Hot Sheet
Trade ECYT Now!
Endocyte, Inc. (NASDAQ: ECYT) reported Q2 EPS of ($0.15), versus $0.35 reported last year. Revenue for the quarter came in at $7.8 million versus the consensus estimate of $0 .
For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- Micron Technology, Inc. (MU) Tops Q3 EPS by 2c
- John Wiley (JW-A) Misses Q4 EPS by 9c; Names New CFO; Updates on Restructuring
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
